CDC defines Clostridioides difficile (C. diff) infection as a significant healthcare burden to patients and physicians, labeling C. diff as…
Ferring and Rebiotix, a Ferring Company, will present two oral abstracts describing translational studies of investigational microbiome-based therapeutics RBX2660 and…
Ferring will deliver 11 presentations at the virtual congress; including six oral presentations The new data being presented further underscores…
FOR IMMEDIATE RELEASE – Parsippany, NJ – August 5, 2020– Ferring Pharmaceuticals US is voluntarily recalling all lots on the…
ORTIKOS is available in one convenient pill in two dosage strengths (9mg, 6mg) for the treatment of mild to moderate…
Ferring joins with UCB to promote CIMZIA prefilled syringe for Crohn’s disease in the U.S. Co-promotion strengthens commitment to patients…
Ragans is now responsible for Ferring US commercial, manufacturing and development operations Ragans joined Ferring, a world leader in reproductive…
MEGASET-HR (high responder) study met its primary non-inferiority endpoint, with Menopur-treated patients experiencing a 35.5% ongoing pregnancy rate (OPR) per…
Rebiotix and Ferring are the first to announce positive preliminary results on primary efficacy endpoint from ongoing pivotal Phase 3…
Fertility House Calls service offered to residents of Greater Denver metro area as part of a pilot program Personalized service…